Price (delayed)
$14.41
Market cap
$1.14B
P/E Ratio
80.06
Dividend/share
N/A
EPS
$0.18
Enterprise value
$1.08B
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide
There are no recent dividends present for NAGE.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.